2cureX
0.55 SEK +6.8%3 investors are following this company
2cureX is a Danish-based biotech company with subsidiary in Hamburg, Germany. The company has made a special sensitivity test, IndiTreat, for oncology clinics that is focused on improving the outcome for cancer patients by improving the efficiency of the individual cancer treatment. IndiTreat uses a biopsy from the individual cancer patient to measure and predict the likely outcome of different available treatments, thereby assisting oncologists to choose the most effective treatment for the individual patient.
Read moreRevenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
2CUREX
Daily low / high price
0.5 / 0.61
SEK
Market cap
9.68M SEK
Turnover
31.59K SEK
Volume
59K
Financial calendar
Interim report
2024-08-22
Business review
2024-11-21
Annual report
2025-02-27
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Kinled Group | 29.9 % | 29.9 % |
Ole Thastrup | 16.7 % | 16.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I 2CUREX AB (PUBL)
RELEASE OF THE 2CUREX AB (PUBL) ANNUAL REPORT
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools